Quietmind Foundation

  • Home
  • Services
    • Photobiomodulation (Light Therapy)
    • Neurofeedback
  • About
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
  • Research
  • Equipment
  • Blog

Leading Edge Commentary

Post-COVID 19 Dementia Increasing Worldwide

3/10/2022

0 Comments

 
COVID ups risks of dementia, cognitive impairment, and decline in older survivorsSadly and not surprisingly, the science media is reporting that the neurological impact of covid 19 is showing increased levels of cognitive decline worldwide. Older adults are having to cope with damage to their lungs and central nervous system. The study noted that the telephone survey measures used were limited in identifying more specific challenges and likely underestimate the size of the problem due to having excluded subjects with any family history of dementia. The global dementia care burden is likely to be greater as a result of the COVID-19 pandemic and so there is even greater need to rapid intervention now that can be easily, safely and cost effectively deployed. Researchers and clinicians at Quietmind Foundation, Neuronic Devices Ltd (Neuronic.online), Baylor Research Institute and the Biophotonic and Neuroimaging Lab•UTexas-Arlington are collaborating to show the effectiveness of self-administered, transcranial infrared light-based therapy to reduce dementia's cognitive and behavioral symptoms. 

The Neuradiant 1070 4Q technology that's being released this month by Neuronic Devices Ltd. 
(see Neuronic.online) is a resource that can address the debilitating impact of COVID 19 on the brain by increasing cortical perfusion and ATP production by stimulating cytochrome c oxidase and improving blood vessel flexibility. In addition, the new independent 4 -quadrant control of pulse frequency allows for renormalization of dysregulated brain network connectivity using the light pulsations to directly changes in EEG activity. 

https://arstechnica.com/science/2022/03/covid-ups-risks-of-dementia-cognitive-impairment-and-decline-in-older-survivors/
0 Comments

March 04th, 2022

3/4/2022

0 Comments

 

Mental disorders in early life are associated with a significantly increased risk of dementia in later years.
Results of a large, longitudinal, population-based study show that individuals hospitalized for a mental health disorder had a fourfold increased relative risk (RR) for developing dementia compared to those who were not hospitalized with a mental illness. This should come as no surprise to psychotherapists and those involved with treating individuals with trauma in their history. Researchers have already reported on the increased incidence of early onset dementia with any history of head trauma and other studies have clearly correlated the exhibiting of violent behavior with the degree of diagnosable brain trauma a person has sustained. 

We must become evermore cognizant of the need to have the differential diagnosis for the entire range of psychiatric and behavioral disorders across the lifespan include a neurotrauma/biophysical/toxicological trauma component. 

Quietmind has evolved it's evaluation protocol according to this tripartite framework, wherein we employ functional medicine to determine the contribution of mold and other neurotoxins, bacterial and viral infections, genetic predispositions and lifestyle factors. That data is combined with individual Quantitative EEG neurophysiological, systems-oriented psychological and  neuropsychiatric assessments.   


Article click here: www.medscape.com/

0 Comments

​Mental Illness Tied to Increased Dementia Risk

3/4/2022

0 Comments

 
Batya Swift Yasgur, MA, LSW March 02, 2022
www.medscape.com/

This article increases the clarity as to how severe emotional stress and dysregulation contribute to the development of neurodegenerative disorders like Alzheimer's, and Parkinson's disease. We have to come to see how mind and body work together to enhance or destroy our capacity for health and well being. Anyone who has been hospitalized for psychiatric illness is at a 4 fold greater risk of developing a neurodegenerative disorder than those who have not been hospitalized. 
Greater attention and effort needs to be placed toward prevention and reducing hospitalization for people experiencing emotional crises.
​


0 Comments

    QMF News

    Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. 

    Archives

    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    August 2022
    July 2022
    June 2022
    April 2022
    March 2022
    February 2022
    January 2022
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    April 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    April 2018
    March 2018
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017

    Categories

    All
    Alzheimer's
    Biofeedback
    Breathing Training
    Dementia
    Dementia Treatment
    Drug Free Anxiety Treatment
    Infrared Light
    Light Therapy
    Neurofeedback
    Neurotherapy
    Panic Disorder
    Photobiomodulation
    Relaxation
    TBI Treatment
    Therapy

    RSS Feed

Powered by Create your own unique website with customizable templates.
  • Home
  • Services
    • Photobiomodulation (Light Therapy)
    • Neurofeedback
  • About
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
  • Research
  • Equipment
  • Blog